TriMas (NASDAQ:TRS) Reaches New 12-Month Low – Here’s Why

TriMas Co. (NASDAQ:TRS) shares reached a new 52-week low on Wednesday . The company traded as low as $22.24 and last traded at $22.30, with a volume of 5301 shares. The stock had previously closed at $22.74.

Wall Street Analyst Weigh In

TRS has been the subject of a number of analyst reports. BWS Financial reissued a “buy” rating and issued a $40.00 price objective on shares of TriMas in a report on Tuesday, November 5th. StockNews.com raised shares of TriMas from a “sell” rating to a “hold” rating in a research note on Wednesday, November 13th.

TriMas Stock Performance

The stock has a fifty day moving average of $25.62 and a 200-day moving average of $25.53. The stock has a market capitalization of $938.02 million, a PE ratio of 36.13 and a beta of 0.67. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60.

TriMas (NASDAQ:TRS) last posted its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.14). The company had revenue of $229.36 million during the quarter, compared to the consensus estimate of $239.33 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. TriMas’s quarterly revenue was down 2.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.57 EPS. Equities analysts anticipate that TriMas Co. will post 1.69 earnings per share for the current fiscal year.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.69%. The ex-dividend date was Tuesday, November 5th. TriMas’s payout ratio is 25.00%.

Institutional Investors Weigh In On TriMas

Several hedge funds have recently bought and sold shares of TRS. Algert Global LLC raised its holdings in shares of TriMas by 4.2% during the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after acquiring an additional 639 shares in the last quarter. FMR LLC grew its holdings in TriMas by 1.7% during the third quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock valued at $1,125,000 after purchasing an additional 729 shares during the last quarter. Rhumbline Advisers raised its position in shares of TriMas by 1.4% in the second quarter. Rhumbline Advisers now owns 69,328 shares of the industrial products company’s stock valued at $1,772,000 after purchasing an additional 985 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of TriMas by 3.3% in the third quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock worth $982,000 after buying an additional 1,227 shares during the last quarter. Finally, Inspire Investing LLC boosted its holdings in shares of TriMas by 17.4% during the 3rd quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock worth $412,000 after buying an additional 2,389 shares during the period. 99.42% of the stock is owned by hedge funds and other institutional investors.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.